Coverage of our peer-reviewed research in the healthcare and mainstream press.
A special report from Modern Healthcare on achieving transparency in healthcare highlighted a statistic from a study published in the February 2016 issue of The American Journal of Managed Care® (AJMC®). That study, titled “Characterizing Health Plan Price Estimator Tools: Findings From a National Survey,” found that just 45% of plans with cost-estimator tools used their negotiated rates with providers to calculate the estimate. Incorporating more complete data into transparency tools may increase their impact on consumers’ choices, the report stated.
MobiHealthNews published an article about health technology company AbleTo’s plans to use the $36.6 million in funding it has received from investors. The article referenced a study published in the February 2015 issue of AJMC® that demonstrated the platform’s ability to improve outcomes for health plan enrollees. “Leveraging Remote Behavioral Health Interventions to Improve Medical Outcomes and Reduce Costs” presented encouraging findings, including lower hospitalizations, among Aetna members receiving the AbleTo intervention.
POSITIVE Trial Update on Patients With Breast Cancer Attempting Pregnancy
December 8th 2023At last year’s San Antonio Breast Cancer Symposium, POSITIVE trial primary outcome data were presented on breast cancer–free interval, with women who paused endocrine therapy to attempt pregnancy having a similarly small rate of recurrence vs external controls from the SOFT and TEXT trials: 8.9% vs 9.2%.
Read More
Dr Kathryn Lindley on Pregnancy-Related Cardiovascular Care Gaps and Training Initiatives
December 8th 2023Cardiologists need skills in risk assessment, contraception counseling, and hypertension management for pregnant patients, according to Kathryn Lindley, MD, FACC, Vanderbilt University Medical Center.
Read More
Real-World Data Show Poor Outcomes Among Patients With ACS and Blood Cancers
December 8th 2023A real-world analysis found that patients with acute coronary syndrome who were also diagnosed with a hematologic malignancy had worse survival outcomes, and patients with multiple myeloma were overrepresented in the population.
Read More